Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in NIDDM patients

Lancet. 1998 Aug 8;352(9126):454. doi: 10.1016/S0140-6736(05)79188-1.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Albuminuria / genetics
  • Case-Control Studies
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetic Nephropathies / enzymology*
  • Diabetic Nephropathies / genetics*
  • Gene Frequency / genetics
  • Humans
  • Japan
  • Methylenetetrahydrofolate Reductase (NADPH2)
  • Middle Aged
  • Oxidoreductases Acting on CH-NH Group Donors / genetics*
  • Polymorphism, Genetic / genetics*

Substances

  • Oxidoreductases Acting on CH-NH Group Donors
  • Methylenetetrahydrofolate Reductase (NADPH2)